MuSiC4Diabetes at Diatec 2026 in Berlin
On 23 January, MuSiC4Diabetes was featured in the Diatec panel “Breakthrough Projekte aus der DACH-Region” (Breakthrough Projects from Germany, Austria and Switzerland), chaired by Norbert Hermanns (FIDAM) and Peter Diem (Diabetesschweiz).
Diatec is an annual conference dedicated to digitalisation in diabetes care and management, bringing together scientists, industry representatives, health insurance stakeholders and people living with diabetes. Interoperability was the central focus of this year’s event, which was organised with the involvement of MuSiC4Diabetes consortium partners Norbert Hermanns and Dominic Ehrmann from FIDAM. While the afternoon plenary sessions had already outlined the opportunities of continuous glucose monitoring and dual glucose–ketone monitoring systems, MuSiC4Diabetes coordinator Martin Richter (Fraunhofer EMFT) explored these topics further during his presentation in the DACH symposium. Alongside MuSiC4Diabetes, two other European Union–funded projects, PRAESIIDIUM and MELISSA, presented their latest results on the use of artificial intelligence and algorithmic forecasting in diabetes care.
Martin Richter opened his presentation by outlining the vision of MuSiC4Diabetes: reducing the daily burden on people living with diabetes through the development of an implantable device that integrates continuous monitoring, algorithmic forecasting and automated insulin delivery. With this approach, patients would require an insulin refill only every three months, while the micro-pump would need to be replaced only every ten years.
“We aim to develop a device that guarantees safe handling, is robust to disturbances, highly precise, and affordable,” Richter explained.
Besides drawing on his extensive expertise in micropump technology, Richter also addressed further key aspects of MuSiC4Diabetes ranging from algorithm-based sensing and the benefits of intraperitoneal insulin delivery to the psychological advantages of unobtrusive diabetes management. The lively discussion following his presentation clearly demonstrated that Diatec 2026, with its strong focus on interoperability, provided an excellent platform for exchange and for further advancing transnational research projects on diabetes management.




